Abstract:Acute pancreatitis (AP) is a common but often self-limiting disease in the majority of patients. However, in the minority, who may progress to moderately severe or severe AP, high mortality risk has been reported. Infected pancreatitis necrosis (IPN) in necrotising pancreatitis has been shown to result in more than twice the mortality rate compared with in sterile pancreatic necrosis. This raises the question on whether prophylactic antibiotics (PABs) should be given in subgroups of AP to prevent superimposed infection to improve survival outcomes. Despite numerous randomised controlled trials (RCTs), meta-analyses, and guidelines on the management of AP, there is a lack of strong evidence to suggest the use of PABs in AP. Additionally, use of PABs is associated with antimicrobial resistance. Considerable heterogeneity exists and limits the interpretation of results—subgroup of AP benefitting from PAB use, choice/class of PAB, and timing of administration from symptom onset and duration of PAB use. Only a minority of existing meta-analyses suggest mortality benefits and reduction in IPN. The majority of existing guidelines do not recommend the use of PABs in AP. More research is required to make more definitive conclusions. Currently, PAB should only be administered after multidisciplinary discussions led by pancreatology experts.

What problem does this paper attempt to address?

### Problems the Paper Attempts to Address This paper aims to explore the effectiveness and safety of using prophylactic antibiotics (PABs) in patients with acute pancreatitis (AP). Specifically, the paper focuses on the following aspects: 1. **Effectiveness in Preventing Infections**: In patients with acute pancreatitis, especially those with moderately severe to severe acute pancreatitis (SAP), the incidence of infected pancreatic necrosis (IPN) is high and is associated with higher mortality rates. The paper investigates whether the use of prophylactic antibiotics in these patients can effectively prevent infections and thereby improve survival rates. 2. **Contradictory Results in Existing Studies**: Despite numerous randomized controlled trials (RCTs), meta-analyses, and guidelines, the application of prophylactic antibiotics in acute pancreatitis remains controversial. The results of different studies are inconsistent; some studies show that prophylactic antibiotics can reduce mortality and infection rates, while others do not find significant effects. The paper attempts to explain these contradictory results by synthesizing existing literature. 3. **Rationality and Safety of Antibiotic Use**: The use of prophylactic antibiotics may lead to increased antibiotic resistance, which is a global public health issue. The paper discusses the potential risks of using prophylactic antibiotics in patients with acute pancreatitis and emphasizes the importance of rational antibiotic use. 4. **Recommendations from Clinical Guidelines**: Most current international guidelines do not recommend the routine use of prophylactic antibiotics in all patients with acute pancreatitis, especially in mild cases. However, in actual clinical practice, many surgeons still use prophylactic antibiotics. The paper explores the reasons for this phenomenon and provides suggestions for improvement. ### Main Conclusions 1. **Lack of Strong Evidence for Universal Use**: Although some meta-analyses suggest that prophylactic antibiotics may be beneficial in patients with moderately severe to severe acute pancreatitis, there is generally a lack of strong evidence to support the routine use of prophylactic antibiotics in all patients with acute pancreatitis. 2. **Potential Benefits in Specific Subgroups**: There may be certain benefits for patients with moderately severe to severe acute pancreatitis, particularly those who use prophylactic antibiotics in the early stages. However, these results require further validation through high-quality studies. 3. **Concerns About Antibiotic Resistance**: Overuse of prophylactic antibiotics may lead to increased antibiotic resistance, so their use should be cautious and follow the recommendations of a multidisciplinary team. 4. **Compliance Issues in Clinical Practice**: Despite clear guidelines, many surgeons still use prophylactic antibiotics in actual clinical practice, possibly due to fear of patient deterioration or lack of effective governance mechanisms. In summary, this paper aims to provide clinicians with the latest evidence and guidance on the use of prophylactic antibiotics in acute pancreatitis by reviewing existing literature comprehensively, with the goal of improving patient outcomes and reducing the risk of antibiotic resistance.

The Ongoing Debate on the Use of Prophylactic Antibiotics in Acute Pancreatitis—Is There a Conclusion? A Comprehensive Narrative Review

[Antibiotic prophylaxis in acute pancreatitis--is the evidence good enough?]

Appropriate Use of Antibiotics in Acute Pancreatitis: A Scoping Review

Reactive Oxygen Species and Oxidative Stress in Acute Pancreatitis: Pathogenesis and New Therapeutic Interventions

Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials.

Antibiotic Therapy in Acute Pancreatitis: from Global Overuse to Evidence Based Recommendations

A narrative review of acute pancreatitis and its diagnosis, pathogenetic mechanism, and management

Prognostic significance of organ failure and infected pancreatic necrosis in acute pancreatitis: An updated systematic review and meta-analysis

Prognostic Significance of Organ Failure and Infected Pancreatic Necrosis in Acute Pancreatitis: an Updated Systematic Review and Meta‐analysis

Effect of Early Antibiotic Treatment Strategy on Prognosis of Acute Pancreatitis

Antibiotics prophylaxis in acute necrotizing pancreatitis: an update.

Recent Treatment Strategies for Acute Pancreatitis

Systematic Review of Volume and Methodological Quality of Randomised Trials in Acute Pancreatitis

Prevention of severe change in acute pancreatitis: prediction and prevention

IDDF2021-ABS-0134 Organ Failure and Infected Pancreatic Necrosis As Determinants of Mortality in Patients with Acute Pancreatitis: an Updated Systematic Review and Meta-Analysis

Pharmacological approach to acute pancreatitis

Evidence-Based Approach to the Surgical Management of Acute Pancreatitis

Recent developments in acute pancreatitis

Management and outcomes of acute pancreatitis patients over the last decade: A US tertiary-center experience

Transition of early-phase treatment for acute pancreatitis: An analysis of nationwide epidemiological survey

Effectiveness and safety of probiotics on patients with severe acute pancreatitis: A systematic review and meta-analysis